Table 2:
Baseline (n=83) | 6-weeks (n=83) | Reproducibility | ||||||
---|---|---|---|---|---|---|---|---|
OGTT Feature | Sensitivity | Specificity | ROC-AUC (95% CI) |
Sensitivity | Specificity | ROC-AUC (95% CI) |
Kappa | 95% CI |
Morphological features | ||||||||
Glucose peak >30 mins | 0.70 | 0.71 | 0.71 (0.55 – 0.86) |
0.58 | 0.62 | 0.60 (0.45 – 0.76) |
0.23 | 0.02–0.44 |
Monophasic curve | 0.60 | 0.53 | 0.57 (0.40 – 0.74) |
0.58 | 0.48 | 0.53 (0.37 – 0.69) |
0.23 | 0.02–0.43 |
1-hr glucose≥155mg/dL | 0.40 | 0.95 | 0.67 (0.51 – 0.83) |
0.33 | 0.98 | 0.66 (0.52 – 0.79) |
0.42 | 0.07–0.77 |
COMBO | 0.66 | 0.75 | 0.71 (0.56–0.85) |
0.41 | 0.73 | 0.57 (0.42–0.72) |
0.46 | 0.30–0.61 |
Gold-standard criteria | ||||||||
Fasting glucose ≥100 mg/dL | 0.38 | 0.04–0.72 | ||||||
2-hr glucose ≥140 mg/dL | 0.28 | −0.08–0.64 |
OGTT: oral glucose tolerance test; COMBO: glucose peak>30mins and/or 1-hr glucose ≥155mg/dL.